HUMANIZED MOUSE MODELS FOR ASSESSING IMMUNE CELL THERAPY

摘要

Provided herein are humanized mouse models and methods for determining whether administration of engineered immune cell therapies likely elicit cytokine release syndrome and/or determining the efficacy of an anti-disease therapy. Further, the models provided herein may be used to test the efficacy of different anti-CRS therapies.